D. Lansing Taylor

dblp:156/9760 · DBLP profile ↗
← Back
5ranked-venue papers
0as first author
1since 2021 · last 2021
0000-0001-6947-1343ORCID · verified

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 5 · 1 since 2021Graphics, computer vision, multimedia, augmented reality and games · 1

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
2 papers
Bioinformatics and computational biology · 100%

Topics — the 4 heaviest of 5, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › molecular informatics › cheminformatics
chemogenomics
0.412020
QuartataWeb: Integrated Chemical-Protein-Pathway Mapping for Polypharmacology and Chemogenomics · Bioinform. 2020
Bioinformatics and computational biology › drug discovery › drug design
polypharmacology
0.412020
QuartataWeb: Integrated Chemical-Protein-Pathway Mapping for Polypharmacology and Chemogenomics · Bioinform. 2020
Bioinformatics and computational biology › drug discovery
drug-target interaction prediction
0.212015
BalestraWeb: efficient online evaluation of drug-target interactions · Bioinform. 2015
Bioinformatics and computational biology › drug discovery
drug-target interaction
0.112020
QuartataWeb: Integrated Chemical-Protein-Pathway Mapping for Polypharmacology and Chemogenomics · Bioinform. 2020

Methods — techniques the papers use, named apart from their topics

database integration · 0.4probabilistic matrix factorization · 0.2collaborative filtering · 0.2
YearPublicationVenuePosition
2021 Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells
abstract
Aberrant signaling through insulin (Ins) and insulin-like growth factor I (IGF1) receptors contribute to the risk and advancement of many cancer types by activating cell survival cascades. Similarities between these pathways have thus far prevented the development of pharmacological interventions that specifically target either Ins or IGF1 signaling. To identify differences in early Ins and IGF1 signaling mechanisms, we developed a dual receptor (IGF1R & InsR) computational response model. The model suggested that ribosomal protein S6 kinase (RPS6K) plays a critical role in regulating MAPK and Akt activation levels in response to Ins and IGF1 stimulation. As predicted, perturbing RPS6K kinase activity led to an increased Akt activation with Ins stimulation compared to IGF1 stimulation. Being able to discern differential downstream signaling, we can explore improved anti-IGF1R cancer therapies by eliminating the emergence of compensation mechanisms without disrupting InsR signaling.
Cemal Erdem, Adrian V. Lee, D. Lansing Taylor, Timothy R. Lezon
PLoS Comput. Biol.3
2020 QuartataWeb: Integrated Chemical-Protein-Pathway Mapping for Polypharmacology and Chemogenomics
abstract
SUMMARY: QuartataWeb is a user-friendly server developed for polypharmacological and chemogenomics analyses. Users can easily obtain information on experimentally verified (known) and computationally predicted (new) interactions between 5494 drugs and 2807 human proteins in DrugBank, and between 315 514 chemicals and 9457 human proteins in the STITCH database. In addition, QuartataWeb links targets to KEGG pathways and GO annotations, completing the bridge from drugs/chemicals to function via protein targets and cellular pathways. It allows users to query a series of chemicals, drug combinations or multiple targets, to enable multi-drug, multi-target, multi-pathway analyses, toward facilitating the design of polypharmacological treatments for complex diseases. AVAILABILITY AND IMPLEMENTATION: QuartataWeb is freely accessible at http://quartata.csb.pitt.edu. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Hongchun Li, Fen Pei, D. Lansing Taylor, Ivet Bahar
Bioinform.3
2017 Histological Detection of High-Risk Benign Breast Lesions from Whole Slide Images
Akif Burak Tosun, Luong Nguyen, Nathan Ong, Olga Navolotskaia, Gloria Carter, Jeffrey L. Fine, D. Lansing Taylor, S. Chakra Chennubhotla
MICCAI (2)7
2017 Spatial Statistics for Segmenting Histological Structures in H&E Stained Tissue Images
abstract
Segmenting a broad class of histological structures in transmitted light and/or fluorescence-based images is a prerequisite for determining the pathological basis of cancer, elucidating spatial interactions between histological structures in tumor microenvironments (e.g., tumor infiltrating lymphocytes), facilitating precision medicine studies with deep molecular profiling, and providing an exploratory tool for pathologists. This paper focuses on segmenting histological structures in hematoxylin- and eosin-stained images of breast tissues, e.g., invasive carcinoma, carcinoma in situ, atypical and normal ducts, adipose tissue, and lymphocytes. We propose two graph-theoretic segmentation methods based on local spatial color and nuclei neighborhood statistics. For benchmarking, we curated a data set of 232 high-power field breast tissue images together with expertly annotated ground truth. To accurately model the preference for histological structures (ducts, vessels, tumor nets, adipose, etc.) over the remaining connective tissue and non-tissue areas in ground truth annotations, we propose a new region-based score for evaluating segmentation algorithms. We demonstrate the improvement of our proposed methods over the state-of-the-art algorithms in both region- and boundary-based performance measures.
Luong Nguyen, Akif Burak Tosun, Jeffrey L. Fine, Adrian V. Lee, D. Lansing Taylor, S. Chakra Chennubhotla
IEEE Trans. Medical Imaging5
2015 BalestraWeb: efficient online evaluation of drug-target interactions
abstract
SUMMARY: BalestraWeb is an online server that allows users to instantly make predictions about the potential occurrence of interactions between any given drug-target pair, or predict the most likely interaction partners of any drug or target listed in the DrugBank. It also permits users to identify most similar drugs or most similar targets based on their interaction patterns. Outputs help to develop hypotheses about drug repurposing as well as potential side effects. AVAILABILITY AND IMPLEMENTATION: BalestraWeb is accessible at http://balestra.csb.pitt.edu/. The tool is built using a probabilistic matrix factorization method and DrugBank v3, and the latent variable models are trained using the GraphLab collaborative filtering toolkit. The server is implemented using Python, Flask, NumPy and SciPy.
Murat Can Cobanoglu, Zoltán N. Oltvai, D. Lansing Taylor, Ivet Bahar
Bioinform.3